Literature DB >> 10530781

Expression of mucins and cytokeratins in ovarian cancer cell lines.

M Stimpfl1, B C Schmid, I Schiebel, D Tong, S Leodolter, A Obermair, R Zeillinger.   

Abstract

The expression pattern of the epithelial cell markers MUC1 (CA15-3, EMA), CA125 (OC125), human epithelial antigen HEA (Ber-EP4) and cytokeratins (Ck7, Ck8, Ck7/8, Ck8/18/19) was studied in seven human ovarian cancer cell lines. We analyzed the cell lines by immunofluorescence to determine the surface as well as cytoplasmic expression. Furthermore, we evaluated the mRNA expression of MUC1, Ck18 and Ck19 by reverse transcriptase-polymerase chain reaction (RT-PCR). All cell lines were positive for MUC1. However, expression patterns and staining intensity depended on the different epitope-specific antibodies. CA125, a typical serum marker for ovarian carcinomas, was positive only in two cell lines. HEA was strongly positive in three cell lines, whereas the others expressed the antigen only weakly in the cytoplasm. Ck7 was not expressed in three of the seven cell lines. Ck7/8 was detectable in all cell lines and was strongly expressed in four of them. MUC1 mRNA was expressed by all cell lines as detected by RT-PCR. These findings permit selection of a suitable marker for the detection of disseminated ovarian cancer cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530781     DOI: 10.1016/s0304-3835(99)00246-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Multiple initial culture conditions enhance the establishment of cell lines from primary ovarian cancer specimens.

Authors:  Cara C Bertozzi; Cheng-Yi Chang; Sonya Jairaj; Xiaochuan Shan; Jia Huang; Barbara L Weber; Christina S Chu; Richard G Carroll
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Mar-Apr       Impact factor: 2.416

Review 2.  Microfluidic transport in microdevices for rare cell capture.

Authors:  James P Smith; Alexander C Barbati; Steven M Santana; Jason P Gleghorn; Brian J Kirby
Journal:  Electrophoresis       Date:  2012-10-12       Impact factor: 3.535

3.  The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer.

Authors:  Constanze Banz; Ute Ungethuem; Ralf-Juergen Kuban; Klaus Diedrich; Ernst Lengyel; Daniela Hornung
Journal:  Fertil Steril       Date:  2009-07-30       Impact factor: 7.329

4.  Glycomics analysis of serum: a potential new biomarker for ovarian cancer?

Authors:  G S Leiserowitz; C Lebrilla; S Miyamoto; H J An; H Duong; C Kirmiz; B Li; H Liu; K S Lam
Journal:  Int J Gynecol Cancer       Date:  2007-07-26       Impact factor: 3.437

5.  BACH family members regulate angiogenesis and lymphangiogenesis by modulating VEGFC expression.

Authors:  Batya Cohen; Hanoch Tempelhof; Tal Raz; Roni Oren; Julian Nicenboim; Filip Bochner; Ron Even; Adam Jelinski; Raya Eilam; Shifra Ben-Dor; Yoseph Adaddi; Ofra Golani; Shlomi Lazar; Karina Yaniv; Michal Neeman
Journal:  Life Sci Alliance       Date:  2020-03-04

6.  Interleukin‑8 released by cancer‑associated fibroblasts attenuates the autophagy and promotes the migration of ovarian cancer cells.

Authors:  Suyanee Thongchot; Pranisa Jamjuntra; Suwanit Therasakvichya; Malee Warnnissorn; Alessandra Ferraresi; Peti Thuwajit; Ciro Isidoro; Chanitra Thuwajit
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

7.  Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours.

Authors:  Ricardo Coelho; Lara Marcos-Silva; Nuno Mendes; Daniela Pereira; Catarina Brito; Francis Jacob; Catharina Steentoft; Ulla Mandel; Henrik Clausen; Leonor David; Sara Ricardo
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923

8.  Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin.

Authors:  Joseph W Po; Aflah Roohullah; David Lynch; Anna DeFazio; Michelle Harrison; Paul R Harnett; Catherine Kennedy; Paul de Souza; Therese M Becker
Journal:  J Circ Biomark       Date:  2018-06-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.